Europe Benign Prostatic Hyperplasia Devices Market – Industry Trends and Forecast to 2026

  • Medical Devices
  • Published Report
  • Mar 2019
  • Europe
  • 350 Pages
  • No of Tables: 22
  • No of Figures: 59

Europe Benign Prostatic Hyperplasia Devices Market By Procedure Type (Transurethral Resection of the Prostate (TURP), Prostatic Urethral Lift, Prostatectomy, Laser Surgery, Transurethral Microwave Therapy (TUMT), Transurethral Needle Ablation of the Prostate (TUNA), Prostatic Stenting/Implants, Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers), Country (Germany, France, U.K, Italy, Spain, Netherlands, Switzerland, Russia, Belgium, Turkey, Rest of Europe) – Industry Trends and Forecast to 2026

Benign prostatic hyperplasia is also called as BPH which is a condition in men where the prostate gland is enlarged and is not cancerous. Benign prostatic hyperplasia is also known as benign prostatic obstruction or benign prostatic hypertrophy. The prostate usually goes through 2 main growth stages as a man ages. The first stage happens early in puberty, when prostate doubles in size, whereas the second phase of growth occurs around the age of 25 and continues through most of a man’s life. BPH often happens with the second stage of growth.

Europe benign prostatic hyperplasia devices market is expected to reach at a CAGR of 12.2% in the forecast period of 2019 to 2026.

Segmentation: Europe Benign Prostatic Hyperplasia Devices Market

Europe benign prostatic hyperplasia devices market is segmented based on procedure type and end user.

  • On the basis of procedure type, the market is segmented into transurethral resection of the prostate (TURP), prostatic urethral lift, prostatectomy, laser surgery, transurethral microwave therapy (TUMT), transurethral needle ablation of the prostate (TUNA), prostatic stenting/implants and others. Laser surgery is sub-segmented into holmium lasers, green light laser/PVP and thulium laser based devices. The others segment is sub-segmented into water-induced thermotherapy, high-intensity frequency ultrasound (HIFU), prostatic artery embolization (PAE) and others. Prostatic urethral lift segment is growing at the highest CAGR of 13.6% in the forecast period of 2019 to 2026.

    • In October 2015, Lumenis launched pulse laser systems which can be used for the prostate and stones treatment. The Pulse 50H laser and Pulse 100H systems is designed for the treatment of benign prostatic hyperplasia (BPH) and stones. The additions of pulse products show a key development to current urological solutions. This addition will help in increasing the company’s product line.

  • On the basis of end user, the market is segmented into hospitals and clinics and ambulatory surgical centers. Hospitals and clinics are growing at the highest CAGR of 13.0% in the forecast period of 2019 to 2026.

    • In February 2019, Teleflex Incorporated’s subsidiary Neotract, Inc (U.S.) expanded its UroLift business. Humana which is a one of the nation’s largest private health insurers is now providing insurance coverage for the UroLift system. This will help the company in grasping more customers.

Competitive Analysis: Europe Benign Prostatic Hyperplasia Devices Market

Some of the major players operating in this market are KARL STORZ SE & Co. KG, Olympus Corporation, Richard Wolf GmbH, Lumenis, Urologix, LLC, Boston Scientific Corporation, Coloplast Corp, LISA Laser Products GmbH, Medifocus, Inc., Coloplast Corp, Teleflex Incorporated, Urotech Devices, BD, PROCEPT BioRobotics Corporation, Biolitec AG and others.

Product Launch:

  • In January 2019, Boston Scientific Corporation has launched Rezūm water vapor therapy and the randomized clinical trial results shows that it offers long-lasting results in minimally invasive treatment for benign prostatic hyperplasia (BPH). This product launch will increase the company’s product line.
  • In March 2017, Biolitec has launched XCAVATOR laser fiber which can be used in the benign prostatic hyperplasia (BPH) treatment. The laser fiber can remove tissue on the prostate at a rate of 3 to 4 grams per minute. This new technological advanced product will offer the urologist an attractive option for their surgery and this will help to increase the company’s product line.
  • In January 2016, Medifocus Inc. announced the engagement of the Tanaka Kapec Design Group, Inc. as a lead designer of the next generation Prolieve Thermodilatation System. This combinational therapy helped in offering both immediate and the long term relief in the BPH related symptoms.
  • In October 2015, Lumenis launched pulse laser systems which can be used for the prostate and stones treatment. The Pulse 50H laser and Pulse 100H systems is designed for the treatment of benign prostatic hyperplasia (BPH) and stones. The additions of pulse products show a key development to current urological solutions. This addition will help to increase the company’s product line.
  • In September 2014, Lisa Laser USA has launched RevoLix 200watt for the BPH treatment. It uses the wavelength of 2013 nm, which targets the water in the tissue, providing superior vaporization, cutting and hemostasis of the prostate. The company will be benefitted from the launch as the product launch will increase the company’s product portfolio.
  • In 2011, Urologix signed an exclusive worldwide license for Prostiva RF Therapy System which is used for BPH treatment from Medtronic, Inc. This helped in expanding the product portfolio of the company.

Research Methodology: Europe Benign Prostatic Hyperplasia Devices Market

Primary Respondents:

Key Opinion Leaders (KOL’s): Manufacturer, Healthcare Professionals, Doctors, Nurses, Medical practitioners.

Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and, National Sales Managers.


SKU-

LIST OF TABLES EUROPE BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET

TABLE 1 TYPE OF SURGERY STRATIFIED BY YEAR IN INDIA TABLE 2 EUROPE BENIGN PROSTATE HYPERPLASIA MARKET, BY PROCEDURE TYPE, 2016-2026 (USD MILLION) TABLE 3 EUROPE TRANSURETHRAL RESECTION OF THE PROSTATE (TURP) IN BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY REGION, 2016-2026 (USD MILLION) TABLE 4 EUROPE PROSTATIC URETHRAL LIFT IN BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY REGION, 2016-2026 (USD MILLION) TABLE 5 EUROPE PROSTATECTOMY IN BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY REGION 2016-2026 (USD MILLION) TABLE 6 EUROPE LASER SURGERY IN BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY REGION, 2016-2026 (USD MILLION) TABLE 7 EUROPE TRANSURETHRAL MICROWAVE THERAPY (TUMT) IN BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY REGION, 2016-2026 (USD MILLION) TABLE 8 EUROPE TRANSURETHRAL NEEDLE ABLATION OF THE PROSTATE (TUNA) IN BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY REGION, 2016-2026 (USD MILLION) TABLE 9 EUROPE PROSTATIC STENTING/IMPLANTS IN BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY REGION 2016-2026 (USD MILLION) TABLE 10 EUROPE OTHERS IN BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY REGION, 2016-2026 (USD MILLION) TABLE 11 EUROPE BENIGN PROSTATE HYPERPLASIA DEVICES MARKET, BY END USER, 2016-2026 (USD MILLION) TABLE 12 EUROPE HOSPITALS AND CLINICS IN BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY REGION, 2016-2026 (USD MILLION) TABLE 13 EUROPE AMBULATORY SURGICAL CENTERS IN BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY REGION, 2016-2026 (USD MILLION) TABLE 14 EUROPE BENIGN PROSTATE HYPERPLASIA DEVICES MARKET, BY COUNTRY, 2016-2026 (USD MILLION) TABLE 15 EUROPE BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY PROCEDURE TYPE, 2016-2026 (USD MILLION) TABLE 16 EUROPE LASER SURGERY IN BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY PROCEDURE TYPE , 2016-2026 (USD MILLION) TABLE 17 EUROPE OTHERS IN BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY PROCEDURE TYPE, 2016-2026 (USD MILLION) TABLE 18 EUROPE BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY END USER, 2016-2026 (USD MILLION) TABLE 19 U.K. BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY PROCEDURE TYPE, 2016-2026 (USD MILLION) TABLE 20 U.K. LASER SURGERY IN BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY PROCEDURE TYPE, 2016-2026 (USD MILLION) TABLE 21 U.K. OTHERS IN BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY PROCEDURE TYPE, 2016-2026 (USD MILLION) TABLE 22 U.K. BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY END USER, 2016-2026 (USD MILLION) TABLE 23 GERMANY BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY PROCEDURE TYPE, 2016-2026 (USD MILLION) TABLE 24 GERMANY LASER SURGERY IN BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY PROCEDURE TYPE, 2016-2026 (USD MILLION) TABLE 25 GERMANY OTHERS IN BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY PROCEDURE TYPE, 2016-2026 (USD MILLION) TABLE 26 GERMANY BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY END USER, 2016-2026 (USD MILLION) TABLE 27 SPAIN BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY PROCEDURE TYPE, 2016-2026 (USD MILLION) TABLE 28 SPAIN LASER SURGERY IN BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY PROCEDURE TYPE, 2016-2026 (USD MILLION) TABLE 29 SPAIN OTHERS IN BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY PROCEDURE TYPE, 2016-2026 (USD MILLION) TABLE 30 SPAIN BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY END USER, 2016-2026 (USD MILLION) TABLE 31 FRANCE BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY PROCEDURE TYPE, 2016-2026 (USD MILLION) TABLE 32 FRANCE LASER SURGERY IN BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY PROCEDURE TYPE, 2016-2026 (USD MILLION) TABLE 33 FRANCE OTHERS IN BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY PROCEDURE TYPE, 2016-2026 (USD MILLION) TABLE 34 FRANCE BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY END USER, 2016-2026 (USD MILLION) TABLE 35 ITALY BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY PROCEDURE TYPE, 2016-2026 (USD MILLION) TABLE 36 ITALY LASER SURGERY IN BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY PROCEDURE TYPE, 2016-2026 (USD MILLION) TABLE 37 ITALY OTHERS IN BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY PROCEDURE TYPE, 2016-2026 (USD MILLION) TABLE 38 ITALY BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY END USER, 2016-2026 (USD MILLION) TABLE 39 NETHERLANDS BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY PROCEDURE TYPE, 2016-2026 (USD MILLION) TABLE 40 NETHERLANDS LASER SURGERY IN BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY PROCEDURE TYPE, 2016-2026 (USD MILLION) TABLE 41 NETHERLANDS OTHERS IN BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY PROCEDURE TYPE, 2016-2026 (USD MILLION) TABLE 42 NETHERLANDS BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY END USER, 2016-2026 (USD MILLION) TABLE 43 SWITZERLAND BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY PROCEDURE TYPE, 2016-2026 (USD MILLION) TABLE 44 SWITZERLAND LASER SURGERY IN BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY PROCEDURE TYPE, 2016-2026 (USD MILLION) TABLE 45 SWITZERLAND OTHERS IN BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY PROCEDURE TYPE, 2016-2026 (USD MILLION) TABLE 46 SWITZERLAND BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY END USER, 2016-2026 (USD MILLION) TABLE 47 TURKEY BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY PROCEDURE TYPE, 2016-2026 (USD MILLION) TABLE 48 TURKEY LASER SURGERY IN BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY PROCEDURE TYPE, 2016-2026 (USD MILLION) TABLE 49 TURKEY OTHERS IN BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY PROCEDURE TYPE, 2016-2026 (USD MILLION) TABLE 50 TURKEY BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY END USER, 2016-2026 (USD MILLION) TABLE 51 BELGIUM BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY PROCEDURE TYPE, 2016-2026 (USD MILLION) TABLE 52 BELGIUM LASER SURGERY IN BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY PROCEDURE TYPE, 2016-2026 (USD MILLION) TABLE 53 BELGIUM OTHERS IN BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY PROCEDURE TYPE, 2016-2026 (USD MILLION) TABLE 54 BELGIUM BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY END USER, 2016-2026 (USD MILLION) TABLE 55 RUSSIA BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY PROCEDURE TYPE, 2016-2026 (USD MILLION) TABLE 56 RUSSIA LASER SURGERY IN BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY PROCEDURE TYPE, 2016-2026 (USD MILLION) TABLE 57 RUSSIA OTHERS IN BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY PROCEDURE TYPE, 2016-2026 (USD MILLION) TABLE 58 RUSSIA BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY END USER, 2016-2026 (USD MILLION) TABLE 59 REST OF EUROPE BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET, BY PROCEDURE TYPE, 2016-2026 (USD MILLION)
CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19